A comparison of medication adherence of blonanserin and aripiprazole in schizophrenic patients: a multicenter, randomized, open-label study

Trial Profile

A comparison of medication adherence of blonanserin and aripiprazole in schizophrenic patients: a multicenter, randomized, open-label study

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Aripiprazole (Primary) ; Blonanserin (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms A-BLAS
  • Most Recent Events

    • 01 Sep 2015 Status changed from recruiting to completed, according to results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology.
    • 01 Sep 2015 Results (n=27) presented at the 28th Annual Congress of the European College of Neuropsychopharmacology.
    • 07 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top